The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 18, 2025 for Docon Technologies ....
THYROCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Docon Technologies Private Limited, the promoter holding 71.06% (3,76,56,092 shares) of Thyrocare Technologies, has fully released the pledge on its entire shareholding in Thyrocare. The shares were previously pledged with Vistra ITCL (India) Limited as a debenture trustee to secure existing non-convertible debentures of API Holdings (Docon's parent) worth INR 1,545.38 crore outstanding. The pledge was released on September 16, 2025, because API Holdings raised fresh debentures of up to INR 1,700 crore to fully redeem the old ones. Post-release, the promoter's 71.06% stake in Thyrocare remains fully unencumbered.
Positive for shareholders — the complete removal of the pledge eliminates any risk of forced share sales by the promoter. Promoter's ownership stays unchanged at 71.06%, indicating no change in control intent.